# Aizant Drug Research Solutions Private Ltd., Hyderabad, India – FDA Inspections

Source: https://www.keypedia.com/companies/aizant-drug-research-solutions-private-ltd/1a2d8dae-2eb4-4bc8-b36b-e94775bccd50

> Inspection records and compliance data for Aizant Drug Research Solutions Private Ltd. in Hyderabad. 10 FDA inspections on record, 4 Form 483s, last inspected July 31, 2026.

---

## Details

- Name: Aizant Drug Research Solutions Private Ltd.
- FEI Number: 3008243902
- Business Operations: CLINICAL BIOEQUIVALENCE OR BIOAVAILABILITY STUDY, FDF MANUFACTURE
- Address Line 1: Survey No 172&173, Dulapally Village, Dundigal-Gandimaisamma Mandal, Medchal-Malkhajgiri, Apparel Park Rd
- City: Hyderabad
- Country Name: India
- Address: Survey No 172&173, Dulapally Village, Dundigal-Gandimaisamma Mandal, Medchal-Malkhajgiri, Apparel Park Rd, Hyderabad, India
- Country: India

## Related Documents

- [483 - Aizant Drug Research Solutions Private Ltd. - 2026-07-31](https://www.keypedia.com/records/483/aizant-drug-research-solutions-private-ltd/e9bbc5aa-20d3-440a-9529-d84a98066f46) — source: FDA, date: July 31, 2026
- [FDA Inspection 1328790 - Aizant Drug Research Solutions Private Ltd. - 2026-07-31](https://www.keypedia.com/records/fda_inspections/aizant-drug-research-solutions-private-ltd/a86deacc-188a-4bf6-9acd-c068a644fc12) — source: FDA, date: July 31, 2026
- [483 - Aizant Drug Research Solutions Private Ltd. - 2025-11-14](https://www.keypedia.com/records/483/aizant-drug-research-solutions-private-ltd/15b6ff35-0140-4042-8f71-829673898523) — source: FDA, date: November 14, 2025
- [FDA Inspection 1301216 - Aizant Drug Research Solutions Private Ltd. - 2025-11-14](https://www.keypedia.com/records/fda_inspections/aizant-drug-research-solutions-private-ltd/4f556e06-b94d-4f83-9f09-8d15e4234cc0) — source: FDA, date: November 14, 2025
- FDA Inspection 1301216 - Aizant Drug Research Solutions Private Ltd. - 2025-11-14 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 14, 2025
- FDA Inspection 1207686 - Aizant Drug Research Solutions Private Ltd. - 2023-04-28 — classification: No Action Indicated (NAI), source: FDA, date: April 28, 2023
- FDA Inspection 1207686 - Aizant Drug Research Solutions Private Ltd. - 2023-04-28 — classification: No Action Indicated (NAI), source: FDA, date: April 28, 2023
- [FDA Inspection 1198206 - Aizant Drug Research Solutions Private Ltd. - 2023-01-25](https://www.keypedia.com/records/fda_inspections/aizant-drug-research-solutions-private-ltd/1eb2ba96-2b19-4f06-b949-790c52fd48c8) — classification: No Action Indicated (NAI), source: FDA, date: January 25, 2023
- [483 - Aizant Drug Research Solutions Private Ltd. - 2020-01-24](https://www.keypedia.com/records/483/aizant-drug-research-solutions-private-ltd/296de81a-691b-481d-8877-b189116361d0) — source: FDA, date: January 24, 2020
- [FDA Inspection 1115743 - Aizant Drug Research Solutions Private Ltd. - 2020-01-24](https://www.keypedia.com/records/fda_inspections/aizant-drug-research-solutions-private-ltd/5683187f-016a-4857-bf2c-f553475a8680) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 24, 2020
- FDA Inspection 1095186 - Aizant Drug Research Solutions Private Ltd. - 2019-05-03 — classification: No Action Indicated (NAI), source: FDA, date: May 3, 2019
- [FDA Inspection 1089625 - Aizant Drug Research Solutions Private Ltd. - 2019-03-15](https://www.keypedia.com/records/fda_inspections/aizant-drug-research-solutions-private-ltd/60be0c9e-c6c1-4041-bfc5-17f19d8569d2) — classification: No Action Indicated (NAI), source: FDA, date: March 15, 2019
- FDA Inspection 1058764 - Aizant Drug Research Solutions Private Ltd. - 2018-07-13 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 13, 2018

## Related Companies

- [AXXELENT PHARMA SCIENCE PRIVATE LIMITED](https://www.keypedia.com/companies/axxelent-pharma-science-private-limited/0e17ded9-51c9-4db9-9ceb-e39cb2d439db)
- [Torrent Pharmaceuticals Limited](https://www.keypedia.com/companies/torrent-pharmaceuticals-limited/f6a46248-6051-4cd6-8fa4-220f0a33652c)
- [Caplin Steriles Limited](https://www.keypedia.com/companies/caplin-steriles-limited/af5b53d8-1adc-41f4-ab8d-0149b3b5b9cb)
- [HP Halden Pharma AS](https://www.keypedia.com/companies/hp-halden-pharma-as/2c8c6d51-da3a-476a-9abd-da411b527728)
- [Digestive Care Inc](https://www.keypedia.com/companies/digestive-care-inc/c4de8703-81c2-4afc-9e51-392b626b8e63)
- [Cerovene Inc.](https://www.keypedia.com/companies/cerovene-inc/f23e944b-ef46-45b3-8177-af154b404c08)
- [Bora Pharmaceuticals (frmly: TWI Pharmaceuticals, Inc.)](https://www.keypedia.com/companies/bora-pharmaceuticals-frmly-twi-pharmaceuticals-inc/103fb1af-ac77-4f76-9476-8430e4586638)
- [Kelix bio (Malta) Ltd.](https://www.keypedia.com/companies/kelix-bio-malta-ltd/3595e81b-9a31-4dcc-b529-e58034aabdf7)
- [Otsuka Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/otsuka-pharmaceutical-co-ltd/4106c23b-a243-4485-8ab6-a3dd8a7258ad)
- [CMIC CMO USA Corporation](https://www.keypedia.com/companies/cmic-cmo-usa-corporation/026de3c9-7077-4859-bf21-6304c0c50f29)

## Related Officers

- [Professor](https://www.keypedia.com/people/liming-zhang/6c93b721-8725-4d87-8a42-254f3de5e49d)
- [Sylvestre K. Dossou](https://www.keypedia.com/people/sylvestre-k-dossou/962f9277-7643-4f66-add9-1c3553fa1c14)
- [Damaris Y. Hernandez](https://www.keypedia.com/people/damaris-y-hernandez/ca16093e-047b-4bf1-bcc1-c439cff21e8a)
